medigraphic.com
ISSN 2448-8909 (Print)

2004, Number 5

Next >>

Med Crit 2004; 18 (5)

Spirometric arterial gases alterations on the diagnosis of chronic obstructive pulmonary disease

Luna SOJ, García HI, Díaz LPMA, Espinola RG, Mújica HM, Olvera CA

Language: Spanish
References: 13
Page: 145-147
PDF size: 47.30 Kb.


ABSTRACT

Objective: To determine the alterations on spirometry and arterial gases, as well as the classification in stages of the Chronic Obstructive Pulmonary Disease (COPD). Design: Retrospective study. Setting: Cardiopulmonary Physiology Laboratory of a third level care hospital, Mexico City. Patients: The files of 2,237 patients were reviewed; of these, 544 (282 men and 262 women, mean age 58.3 ± 15.2 and 43.8 ± 12.1 yrs, respectively) with COPD were analyzed. Interventions: None. Results: Of the 544 studied patients, 65 (11.9%), 86 (15.8%), 10.3% and 75 (13.8%) had mild, moderate, severe and very severe spirometric alterations; 166 (30.5%), 129 (23.7%), 130 (23.9%), 44 (8%) and 3.6%) had mild, moderate, important, severe and very severe hypoxemia. Conclusion: The spirometry is a useful tool for the follow-up of COPD patients.


REFERENCES

  1. Rieves RD, Bass D, Carter RR, Griffith JE, Norman JR. Severe COPD and acute respiratory failure. Correlates for survival at the time of tracheal intubation. Chest 1993;104: 854-860.

  2. Global Initiative for Chronic Obstructive Lung Disease. National Heart, Lung and Blood Institute: Claude Lenfant, MD World Health Organization: Nikolai Khaltaev, MD (April 1998 Workshops Panel and Reviewers).

  3. Executive Summary, NHLBI/WHO Workshop Report: Global Strategy for the Diagnosis, Management, and Prevention of COPD. 2003.

  4. Pocket Guide to COPD Management and Prevention. Summary of Patient care information for primary health care professionals 2003.

  5. Europea Respiratory Society. Standarized Lung Function. Eur Respir J 1993;6 Suppl 16.

  6. American Thoracic Society. Standardization of Spirometry 1994 update. Am J Respiratory Critical Care Med 1995;152: 1107-1136.

  7. American Thoracic Society. Single Breth Carbon Monoxide Diffusing Capacity (Transfer Factor). Recommendations for standard technique. Am Rev Respir Dis 1987;136: 1299-1307.

  8. American Thoracic Society. Lung function Testing: Selection of reference values and interpretative. Am Rev Respir Dis 1991;144:1202-1218.

  9. Capro RO, Lockey. Normal spirometric values in healthy hispanic americans. Chest 1990;98:1453-1439.

  10. Enright PL, JohnsonLR, Connet JE. Spirometry in the Lung Health study Methods and quality control. Am Rev Respir Dis 1991;143:1215-1223.

  11. Masa JF, Sobradillo V, Villasante C, Jiménez-Ruiz CA, Fernández-Fau L, Viejo JL, Miravitlles M. Costs of chronic obstructive pulmonary disease in Spain. Estimation from a population- based study. Arch Bronconeumol 2004;40(2): 72-9.

  12. Tovar JM, Gums JG. Monitoring Pulmonary Function in Asthma and COPD: Ponint- of-Care Testing- Ann Pharmacother. 2004;38(1):126-33.

  13. Hasen-Flaschen J. Chronic Obstructive Pulmonary Disease: the last year of life. Respir Care 2004;49(1):90-86.




2020     |     www.medigraphic.com